You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LKB1-inactive adenocarcinoma

Showing 26 - 50 of 2,918
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial (Fruquintinib)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Oct 17, 2023

Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • Tianjin, Tianjin, China
    Xuewei Ding
Aug 2, 2023

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 22, 2023

Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of

Completed
  • Pancreas Cancer
    • (no location specified)
    Jul 15, 2023

    Periampullary Adenocarcinoma Trial in Wuhan (laparoscopic pancreaticoduodenectomy, open pancreaticoduodenectomy)

    Not yet recruiting
    • Periampullary Adenocarcinoma
    • laparoscopic pancreaticoduodenectomy
    • open pancreaticoduodenectomy
    • Wuhan, Hubei, China
      Department of Biliary and Pancreatic Surgery, Tongji Hospital, A
    Mar 15, 2023

    Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

    Recruiting
    • Gastroesophageal Junction Adenocarcinoma
    • Beijing, China
      Peking Union Medical College Hospital
    Jun 15, 2023

    Alcohol Use Disorder Trial (Citicoline (cytidine diphosphate-choline), Placebo oral capsule)

    Not yet recruiting
    • Alcohol Use Disorder
    • Citicoline (cytidine diphosphate-choline)
    • Placebo oral capsule
    • (no location specified)
    May 11, 2023

    Work Experience in Patients With Stage I-III Prostate Cancer

    Recruiting
    • Prostate Adenocarcinoma
    • +3 more
    • Interview
    • Questionnaire Administration
    • Phoenix, Arizona
    • +324 more
    Dec 21, 2022

    Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced

    Recruiting
    • Gastric Cancer
    • Gastric Adenocarcinoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 4, 2023

    Crohn's Disease Trial in Worldwide (Guselkumab, Placebo)

    Recruiting
    • Crohn's Disease
    • San Diego, California
    • +134 more
    Mar 13, 2023

    HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

    Not yet recruiting
    • HER2-positive Locally Advanced Resectable Gastric Cancer
    • (no location specified)
    Sep 3, 2023

    Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)

    Not yet recruiting
    • Pancreatic Cancer
    • Shanghai, Shanghai, China
      Department of Pancreatic Surgery, Fudan University Shanghai Canc
    Dec 4, 2023

    Minimal Residual Disease Using Multi-omics Approach

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
    • Shanghai, China
      Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
    Nov 29, 2023

    Anatomical-Clinical Base of Adenocarcinoma Pancreatic

    Recruiting
    • Adenocarcinoma
    • +2 more
    • collection of biological samples
    • Bordeaux, France
    • +7 more
    Nov 20, 2023

    Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With

    Recruiting
    • Gastric Cancer
    • +2 more
    • Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
    • Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 18, 2023

    Crohn Disease Trial in New York (Placebo, Bacteriophage preparation)

    Recruiting
    • Crohn Disease
    • Placebo
    • Bacteriophage preparation
    • New York, New York
      The Mount Sinai Hospital
    Jan 6, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

    Not yet recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
    • (no location specified)
    Jul 9, 2023

    Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)

    Recruiting
    • Bile Duct Adenocarcinoma
    • surufatinib plus cadonilimab
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Oct 15, 2023

    Collection of Circulating Biomarkers in Pancreatic Cancer

    Not yet recruiting
    • Pancreas Cancer
    • Obtaining blood for analysis of various circulating biomarkers
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Feb 22, 2023

    Invasiveness for Small-sized Lung Adenocarcinoma

    Recruiting
    • Lung Adenocarcinoma, Stage I
    • Invasiveness diagnosis
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Apr 13, 2023

    Gastric Cancer Stage II, Gastric Cancer Stage III Trial in Qingdao (Robotic radical gastrectomy)

    Recruiting
    • Gastric Cancer Stage II
    • Gastric Cancer Stage III
    • Robotic radical gastrectomy
    • Qingdao, Shandong, China
      Department of Gastrointestinal Surgery, Qingdao University Affil
    Sep 12, 2023

    Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

    Not yet recruiting
    • Gastric Cancer
    • S-1, Oxaliplatin, Cadonilimab
    • (no location specified)
    Jul 10, 2023

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Woodville South, Melbourne, Subiaco (CEND-1, Nab-paclitaxel,

    Completed
    • Pancreatic Cancer
    • Pancreatic Ductal Adenocarcinoma
    • Woodville South, South Australia, Australia
    • +2 more
    Oct 26, 2022

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • CS1001 monoclonal antibody
    • +3 more
    • Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2022